Additional file 2: of Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer

Table S1. Genes in mouse and human version of Myc signatures. Table S2. A. Upregulated and downregulated genes with FDR of 0% in SAM analysis. B: Entinostat signatures. Table S3. The changes in tumor size of MMTV/Neu tumors treated with entinostat. Table S4. 83 genes which significantly decreased at gene expression and copy number levels with q-value 0% by SAM analysis comparing the untreated samples and the samples resistant while on entinostat. Table S5. Multivariate analysis of each Myc signature accounting for clinical features in METABRIC. (XLSX 74 kb